BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25724459)

  • 1. Fibrolamellar hepatocellular carcinoma: a rare but distinct type of liver cancer.
    Andersen JB
    Gastroenterology; 2015 Apr; 148(4):707-10. PubMed ID: 25724459
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver cancer: A model of fibrolamellar carcinoma.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):672. PubMed ID: 26503883
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
    Ward SC; Waxman S
    Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.
    Simon EP; Freije CA; Farber BA; Lalazar G; Darcy DG; Honeyman JN; Chiaroni-Clarke R; Dill BD; Molina H; Bhanot UK; La Quaglia MP; Rosenberg BR; Simon SM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):E5916-25. PubMed ID: 26489647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.
    Darcy DG; Chiaroni-Clarke R; Murphy JM; Honeyman JN; Bhanot U; LaQuaglia MP; Simon SM
    Oncotarget; 2015 Jan; 6(2):755-70. PubMed ID: 25605237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budd-Chiari syndrome as the primary manifestation of a fibrolamellar hepatocellular carcinoma.
    Lamberts R; Nitsche R; de Vivie RE; Peitsch W; Schauer A; Schuster R; Tebbe U; Kreuzer H; Creutzfeldt W
    Digestion; 1992; 53(3-4):200-9. PubMed ID: 1337896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of insulin-like growth factor 1 in human primary liver cancer.
    Ikeda Y; Kajiyama K; Yamashita Y; Ikegami T; Uchiyama H; Soejima Y; Kawanaka H; Ikeda T; Morita M; Oki E; Saeki H; Suehiro T; Mimori K; Sugimachi K; Shirabe K; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Oct; 104(10):334-8. PubMed ID: 24511663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrolamellar Carcinoma: What Is New and Why It Matters.
    Graham RP
    Surg Pathol Clin; 2018 Jun; 11(2):377-387. PubMed ID: 29751881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snapshot liver transcriptome in hepatocellular carcinoma.
    Teufel A; Marquardt JU; Staib F; Galle PR
    J Hepatol; 2012 Apr; 56(4):990-2. PubMed ID: 22173158
    [No Abstract]   [Full Text] [Related]  

  • 11. The molecular point of view of hepatocellular carcinoma.
    Benzoni E
    J Surg Oncol; 2008 Jun; 97(7):565-6. PubMed ID: 18491361
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.
    Zou J; Li H; Huang Q; Liu X; Qi X; Wang Y; Lu L; Liu Z
    Tumour Biol; 2017 Oct; 39(10):1010428317719272. PubMed ID: 29025375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).
    Duan X; Hu J; Wang Y; Gao J; Peng D; Xia L
    Gene; 2014 May; 541(1):67-8. PubMed ID: 24630966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of hepatocellular carcinoma.
    Sherman M
    N Engl J Med; 2008 Nov; 359(19):2045-7. PubMed ID: 18923166
    [No Abstract]   [Full Text] [Related]  

  • 15. Beginnings of a "gene cloud" definition in hepatocellular carcinoma.
    Barry CT
    Chin Clin Oncol; 2017 Feb; 6(1):5. PubMed ID: 27334462
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular carcinoma and gene profiling: back from perspective to reality.
    Braillon A
    Hepatology; 2011 Aug; 54(2):738; author reply 738-9. PubMed ID: 21503944
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer stem cells in hepatocellular carcinomas.
    Das P; Gupta SD
    Indian J Med Res; 2015 Oct; 142(4):362-5. PubMed ID: 26609026
    [No Abstract]   [Full Text] [Related]  

  • 18. Signature genes for both hepatoblastoma and hepatocellular carcinoma.
    Chen F; Li S; Castranova V
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1220-2. PubMed ID: 19749507
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatocellular carcinoma: A role for lncRNA in liver cancer.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2016 Mar; 13(3):122-3. PubMed ID: 26860270
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma.
    Riggle KM; Turnham R; Scott JD; Yeung RS; Riehle KJ
    Pediatr Blood Cancer; 2016 Jul; 63(7):1163-7. PubMed ID: 26990031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.